Browse
Submit Data
Databases
API
Help

Dataset Information

31 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1-Methyl-2-methyl-sulfanyl-6-nitro-1H-benzimidazole.

ABSTRACT: The mol-ecule of the title compound, C9H9N3O2S, is built up from fused five- and six-membered rings connected to methyl-sulfanyl and nitro groups, respectively. The mean plane through the fused ring system is inclined slightly relative to the plane passing through the nitro group [dihedral angle = 3.6?(2)°]. In the crystal, mol-ecules are linked by C-H?O hydrogen bonds and ?-? inter-actions between imidazole rings [inter-centroid distance = 3.667?(3)?Å], forming a three-dimensional network.

SUBMITTER: El Ghozlani M

PROVIDER: S-EPMC3998622 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1-Methyl-2-methyl-sulfanyl-6-nitro-1H-benzimidazole.

El Ghozlani Mohamed M Rakib El Mostapha el M Medaghri-Alaoui Abdelouahid A Saadi Mohamed M El Ammari Lahcen L

Acta crystallographica. Section E, Structure reports online 20140308 Pt 4

The mol-ecule of the title compound, C9H9N3O2S, is built up from fused five- and six-membered rings connected to methyl-sulfanyl and nitro groups, respectively. The mean plane through the fused ring system is inclined slightly relative to the plane passing through the nitro group [dihedral angle = 3.6 (2)°]. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds and π-π inter-actions between imidazole rings [inter-centroid distance = 3.667 (3) Å], forming a three-dimensional network. ...[more]

PMID: 24826123

Similar Datasets

1-Methyl-6-nitro-1H-benzimidazole.

Project description:The title compound, C(8)H(7)N(3)O(2), a potential anti-tumour drug and an anti-oxidant agent, was studied in order to give more insight into structure-function relationships. The 1-methyl-benzimidazole unit of the mol-ecule was found to be exactly planar and the nitro group is inclined at an angle of 10.4 (2)° to the plane of the heterocycle. The bond lengths in the present derivative were analyzed in details and compared with those of the parent unsubstituted analogues in the Cambridge Structural Database. The results have shown that the additional nitro group is not involved in conjugation with the adjacent π-system and hence has no effect on the charge distribution of the heterocyclic ring.

| S-EPMC2961028 | biostudies-literature

2-Methyl-5-nitro-1H-benzimidazole monohydrate.

Project description:In the title compound, C(8)H(7)N(3)O(2)·H(2)O, the 2-methyl-5-nitro-1H-benzimidazole mol-ecule, excluding the methyl H atoms, is approximately planar, with a maximum deviation of 0.137?(1)?Å. The crystal structure is stabilized by water mol-ecules via N-H?O(water), O(water)-H?O and O(water)-H?N hydrogen bonds, forming sheets parallel to the (100) plane. A short inter-molecular contact between the benzene and imidazole rings, with a centroid-centroid distance of 3.6419?(10)?Å, indicates a ?-? inter-action.

| S-EPMC3120310 | biostudies-literature

5-Nitro-2-trifluoro-methyl-1H-benzimidazole monohydrate.

Project description:In the crystal structure of the title compound, C(8)H(4)F(3)N(3)O(2)·H(2)O, the main mol-ecule and the water mol-ecule are linked by an N-H⋯O hydrogen bond. O-H⋯N, O-H⋯O and C-H⋯O hydrogen bonds further link the mol-ecules into sheets.

| S-EPMC3344597 | biostudies-literature

1-Tosyl-2-[(1-tosyl-1H-benzimidazol-2-yl)methyl-sulfanyl]-1H-benzimidazole.

Project description:In the title compound, C(29)H(24)N(4)O(4)S(3), the two N-tosyl-benzimidazolyl unit are connected through a -S-CH(2)- fragment, the dihedral angle between the benzimidazole rings being 76.09?(5)°. The methyl-thio group is disordered with respect to exchange of the S and C atoms in a 0.547?(4):0.453?(4) ratio. In the crystal, C-H?O and C-H?? inter-actions connect adjacent mol-ecules into infinite layers parallel to the ab plane. The crystal packing is further stabilized by a ?-? inter-action [centroid-centroid separation = 3.5187?(4)?Å].

| S-EPMC3089064 | biostudies-literature

5-Chloro-2-methyl-sulfanyl-6-(naphtha-len-1-yl-oxy)-1H-benzimidazole methanol monosolvate.

Project description:In the title compound, C18H13ClN2OS·CH3OH, the dihedral angle between the benzimidazole group and the naphth-yloxy moiety [82.89?(5)°] very near to orthogonality. The H atom in the five-membered ring is disordered with equal occupancies at the two N atoms and the H atom of the methano-lic hy-droxy group is disordered with equal occupancies over two sites at the O atom. The methanol mol-ecule acts as a hydrogen-bond acceptor for the amino H atom and donates a hydrogen bond to the nonprotonated ring N atom. As a result, chains are formed running along the a axis.

| S-EPMC3914104 | biostudies-literature

2-Trifluoro-methyl-1H-benzimidazole.

Project description:The asymmetric unit of the title compound, C(8)H(5)F(3)N(2), consists of two half-mol-ecules, one lies on a mirror plane and the other is generated by twofold rotation symmetry, with the axis running through the trifluoro-methyl C atom and the attached benzimidazole C atom. The two 2-trifluoro-methyl-1H-benzimidazole mol-ecules are connected by N-H⋯N hydrogen bonds involving the disordered NH H atoms into chains running parallel to the c axis. One of the trifluoro-methyl groups is disordered over two orientations of equal occupancy.

| S-EPMC3344623 | biostudies-literature

(R)-(+)-2-{[(3-Methyl-4-nitro-pyridin-2-yl)meth-yl]sulfin-yl}-1H-benzimidazole.

Project description:The title compound, C(14)H(12)N(4)O(3)S, is an inter-mediate of Dexlansoprazole, a proton pump inhibitor (PPI) mainly developed for anti-ulcer activity. The absolute configuration of the title compound was determined as R. The crystal structure reveals that the mol-ecules form chains along the b axis through N-H?N and C-H?O hydrogen-bonded dimers. These chains are connected via weak C-H?O hydrogen bonds.

| S-EPMC3213621 | biostudies-literature

5-Amino-1-methyl-1H-benzimidazole.

Project description:The structure of the title compound, C(8)H(9)N(3), a potential anti-tumour drug, was determined in order to give more insight into its structure-function relationships. The benzimidazole core of the mol-ecule was found to be exactly planar, while the substituents are displaced slightly from the mol-ecular plane [C-C-N-C and C-C-C-N torsion angles of 0.8?(3) and 179.0?(1)° for the methyl and amino groups, respectively]. The bond lengths are analysed in detail and compared with those of the parent unsubstituted analogues. The results show that the lone-pair electrons on the amino N atom are involved in conjugation with the adjacent ? system and hence affect the charge distribution in the heterocycle. Two inter-molecular N-H?N and C-H?N hydrogen bonds have been identified.

| S-EPMC2977244 | biostudies-literature

1-Isopropyl-4-nitro-6-meth-oxy-1H-benzimidazole.

Project description:There are two independent mol-ecules in the asymmetric unit of the title compound, C(11)H(13)N(3)O(3). The inter-planar angles for the two rings of the benzimidazole ring system is 2.21 (12)° in one mol-ecule and 0.72 (12)° in the other. The nitro group is twisted in the same direction relative to the least-squares plane through its attached benzene ring in both mol-ecules, with inter-planar angles of 15.22 (9) and 18.02 (8)°. In the crystal structure, mol-ecules are stacked along the a axis through π-π inter-actions (centroid-centroid distance 4.1954 Å). C-H⋯O hydrogen bonds are also present.

| S-EPMC2961682 | biostudies-literature

Dichloridobis[5-nitro-1-trimethyl-silyl-methyl-1H-benzimidazole-κN]cobalt(II) N,N-dimethyl-formamide solvate.

Project description:The title compound, [CoCl(2)(C(11)H(15)N(3)O(2)Si)(2)]·C(3)H(7)NO, was synthesized from 5-nitro-1-trimethyl-silylmethyl-1H-benzimid-azole and cobalt(II) chloride in dimethyl-formamide. The Co(II) atom is coordinated in a distorted tetra-hedral environment by two Cl atoms and two N atoms. In the crystal structure, there are a number of C-H⋯Cl and C-H⋯O hydrogen-bonding inter-actions between symmetry-related mol-ecules.

| S-EPMC2983604 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data